GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Microbio Co Ltd (ROCO:4128) » Definitions » Capital Expenditure

Microbio Co (ROCO:4128) Capital Expenditure : NT$-48.67 Mil (TTM As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Microbio Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Microbio Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was NT$-24 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-48.67 Mil.

Microbio Co Capital Expenditure Historical Data

The historical data trend for Microbio Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbio Co Capital Expenditure Chart

Microbio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -79.83 -103.96 -43.12 -48.04 -40.24

Microbio Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.06 -6.98 -8.58 -9.62 -23.50

Microbio Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-48.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Microbio Co Ltd (ROCO:4128) » Definitions » Capital Expenditure
Comparable Companies
ROCO:1264 TPE:1702 TPE:1218 TPE:1203 ROCO:7780 TPE:1201 ROCO:4205 TPE:1225 TPE:1217 TPE:1219 XSWX:NESN XPAR:BN SHSE:603288 KHC GIS K NSE:NESTLEIND SHSE:600887 TSE:2802 SZSE:300999
Traded in Other Exchanges
N/A
Address
Yuan Qu Street, No.3, 14th Floor, Sanchongli, Nangang District, Taipei, TWN, 115
Website
https://www.twmicrobio.com
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development, and the sale of dietary supplements. A majority of its revenue is generated from the sale of its dietary supplements.

Microbio Co Headlines

No Headlines